Elekta AB (MEX:EKTAB N) ROCE %: -16.15% (As of Apr. 2026)


MEX:EKTAB N Elekta AB MEX:EKTAB N
79 GF Score
Price MXN126.63
GF Value MXN158.57
! 6 Warning Signs
View Full Analysis

What is Elekta AB ROCE %?

Elekta AB MEX:EKTAB N 79 ROCE % is -16.15% as of Apr. 2026. GuruFocus rates MEX:EKTAB N with a GF Score™ of 79/100 and a GF Value™ of MXN158.57. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Elekta AB's annualized ROCE % for the quarter that ended in Apr. 2026 was -16.15%.

Elekta AB  (MEX:EKTAB N) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Elekta AB ROCE % Related Terms

Elekta AB ROCE % Historical Data

* Premium members only.

The historical data trend for Elekta AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elekta AB ROCE % Chart

Elekta AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.32 8.62 11.25 5.93 0.68

Elekta AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.59 4.69 9.20 1.68 -16.15
MEX:EKTAB N
79GF Score
Elekta AB MEX:EKTAB N
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elekta AB ROCE % Calculation

Elekta AB's annualized ROCE % for the fiscal year that ended in Apr. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Apr. 2026 )  (A: Apr. 2025 )(A: Apr. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Apr. 2026 )  (A: Apr. 2025 )(A: Apr. 2026 )
=190.867/( ( (58115.966 - 24765.019) + (50938.782 - 28465.623) )/ 2 )
=190.867/( (33350.947+22473.159)/ 2 )
=190.867/27912.053
=0.68 %

Elekta AB's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=-3960.96/( ( (52828.358 - 26250.033) + (50938.782 - 28465.623) )/ 2 )
=-3960.96/( ( 26578.325 + 22473.159 )/ 2 )
=-3960.96/24525.742
=-16.15 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -16.15% mean?
Elekta AB (MEX:EKTAB N) has a ROCE % of -16.15% as of Apr. 2026.
Is Elekta AB's ROCE % too high?
Elekta AB's current ROCE % is -16.15%. Overall, Elekta AB has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's ROCE % compare to ABT and SYK?
Elekta AB's ROCE % of -16.15% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elekta AB's current ROCE % is -16.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Elekta AB (MEX:EKTAB N) has a current ROCE % of -16.15%. The stock's GF Value™ is MXN158.57, compared to a current price of MXN126.63 — trading 20.1% below its estimated fair value. The current ROCE % is -16.15%. Elekta AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Elekta AB (MEX:EKTAB N), the current ROCE % is -16.15% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elekta AB (MEX:EKTAB N) Overvalued in 2026?

Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued. The current stock price of MXN126.63 is trading 20.1% below its estimated GF Value™ of MXN158.57.

Key valuation signals for MEX:EKTAB N:

  • ROCE %: -16.15%
  • GF Value™: MXN158.57 vs. price of MXN126.63 (20.1% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the MEX:EKTAB N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elekta AB Business Description

Address Hagaplan 4, Box 7593, Stockholm, SWE, 11368
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
79GF Score

Get the complete analysis for MEX:EKTAB N

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN126.63
Price
MXN158.57
GF Value